Clinical Trials Directory

Trials / Completed

CompletedNCT01329536

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease Compared to Age- and Gender-Matched, Non-Agitated In-Patients With Late-Onset Alzheimer's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Avera McKennan Hospital & University Health Center · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical research study is to determine if a specific genetic allele is involved with the development of agitation in patients with late-onset Alzheimer's Disease (AD). The study will compare the results of genetic testing between two groups: individuals with late-onset AD who show signs of agitation and individuals with late-onset AD who do not show signs of agitation.

Detailed description

Agitation and other behavioral disturbances are a main cause in the need for increasing levels of care for the patient with Alzheimer's disease (AD). And while the pathology of dementia has been studied in great detail, the etiology is considered multi-factorial. The hypothesis behind this clinical study is that the presence of the apo lipoprotein E4 (APO E4) allele will serve to predict which patients with late on-set AD are at greater risk to develop agitation.

Conditions

Timeline

Start date
2010-12-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2011-04-06
Last updated
2011-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01329536. Inclusion in this directory is not an endorsement.